Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital

Not yet recruitingOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
NAFLD - Nonalcoholic Fatty Liver Disease
Interventions
DEVICE

Fibroscan

Fibroscan (transient elastography ) is a non-invasive imaging method that evaluates steatosis and fibrosis by measuring liver stiffness using ultrasonographic sound waves. It is an acceptable alternative to liver biopsy and is fast , reliable, and reproducible, enabling screening and disease follow-up.11 It is now widely used to assess liver fibrosis in various liver diseases; however, currently there is no data on Fibroscan assessment regarding hepatic involvement in SLE patients. The aim of this study was to evaluate fatty liver and liver fibrosis in SLE patients using fibroscan and determine associated factors such as immunosuppressive medications.

All Listed Sponsors
lead

Assiut University

OTHER

NCT06601361 - Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital | Biotech Hunter | Biotech Hunter